Valeant Pharmaceuticals International Inc (NYSE:VRX)

205.32
Delayed Data
As of Apr 17
 -2.04 / -0.98%
Today’s Change
106.00
Today|||52-Week Range
211.57
+43.47%
Year-to-Date

Today’s Trading

Previous close207.36
Today’s open207.21
Day’s range203.46 - 207.41
Volume1,485,122
Average volume (3 months)2,906,632
Market cap$70.0B
Dividend yield--
Data as of 4:01pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+26.42%
Earnings growth (next 5 years)+26.30%
Revenue growth (last year)+43.22%
P/E ratio76.8
Price/Sales5.83
Price/Book12.92

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories-0.27-0.58%
LLYEli Lilly and Co-1.02-1.39%
AZNAstraZeneca-0.71-0.99%
CELGCelgene-2.89-2.48%
Data as of 4:14pm ET, 04/17/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)$2.33
Annual revenue (last year)$8.3B
Annual profit (last year)$913.5M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer, Director &
Executive VP
Howard Bradley Schiller
Corporate headquarters
Laval, Quebec

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers